Evaluation of Efficacy and Safety of Curalin As Add-On Therapy in Adults With Type 2 Diabetes Mellitus

A phase 2 trial registered on ClinicalTrials.gov. The registry status is terminated. It enrolled 135 participants.

Also called NCT05631431

  • Study
  • In this atlas

Overview

Design
Interventional study; randomized; triple masking; primary purpose supportive care
Phase
Phase 2
Enrolled
  • 135 participants (enrolled count) (from the registry)
Sponsor
CuraLife (from the registry)
Registry
  • NCT NCT05631431
Started
(actual) (from the registry)
Primary completion
(actual) (from the registry)
Completion
(actual) (from the registry)
Countries
Israel (from the registry)
Registry status
  • Terminated (from the registry)

Technical summary

Registry record NCT05631431. Randomized; triple masking; primary purpose supportive care. Start 2021-12-14 (actual); primary completion 2023-06-29 (actual). Results not posted.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
Evaluation of Efficacy and Safety of Curalin As Add-On Therapy in Adults With Type 2 Diabetes Mellitus
Condition
Type2 Diabetes
Intervention (Dietary supplement)
Curalin
Lead sponsor
CuraLife (class: industry)

Record details

Record id
cardio:ct-nct05631431
Content hash
5aa3a71263065b0b2d297a347da9d7db8357e985805356858b4eacd8c20f73f3